Mission Pharmacal publishes ‘ABCs of Medical Management of Stones’ as an Apple app
SAN ANTONIO — Mission Pharmacal Co. on Tuesday announced its “ABCs of Medical Management of Stones,” a step-by-step approach to the diagnosis and treatment of nephrolithiasis, or kidney stones, is now available as a mobile application for Apple devices.
“The ABCs of Kidney Stones app may simplify an otherwise complicated diagnosis, guiding the physician through the process using a standard protocol that differentiates between first-time and recurrent stone formers,” stated Dan Crawford, marketing director of the Urological Division of Mission Pharmacal Company. “The app provides an interactive and updated version of the popular ABCs literature, which was developed and co-authored by some of the most respected and recognized thought leaders in the management of kidney stones. Their reputations alone add tremendous credibility to this app.”
The ABCs of Medical Management of Stones, now in its second edition, was recently updated by co-authors Margaret Pearle, Glenn Preminger, David Goldfarb and Donald Griffith, with additional input from Charles Pak, for physicians who were looking for an efficient way to manage the complexities of stone disease. “First with the booklet, and now with the app, the ABCs make the doctors’ job easier. The app will get the ABCs into the hands and pockets of younger physicians or those who prefer to get information electronically,” Crawford said.
The app also will allow physicians to show videos to their patients during a visit with topics including how a kidney stone is formed.
The ABCs of Medical Management of Stones was initially released on iTunes for use on Apple devices because at least 60% of physicians now use an iPad tablet in their practices.
The app will be released for use on an Android platform in coming months.
Avion Pharmaceuticals launches prescription supplements Prenate Enhance and Prenate Restore
ATLANTA — Avion Pharmaceuticals on Tuesday announced the launch of two advanced vitamin formulations as the newest additions to the Prenate Vitamin Family — Prenate Enhance and Prenate Restore.
The new prescription supplements have been designed to support important nutritional supplementation for women during their prenatal and postpartum period, as well as provide the optimal level of vitamins and minerals recommended.
"Avion is excited to be a leader in innovation for the women’s health category by providing two new prescription supplements that have been formulated based on expert recommendations for nutritional supplementation for women both pregnant and postpartum," stated Mike Sullivan, VP sales and marketing for Avion Pharmaceuticals. "Prenate Enhance and Prenate Restore were designed for nutritional support for both moms and babies during this important period in their life."
Prenate Enhance and Prenate Restore are advanced prescription dietary supplements designed for enhanced absorption with ingredients selected for their high absorbability.
Prenate Restore, the first prescription postnatal dietary supplement with probiotics, designed for postpartum supplementation, helps support the needs of both moms and babies post-pregnancy when nutritional stores can often be depleted.
Prenate Enhance and Prenate Restore provide the highest DHA content (400 mg) among leading prescription prenatal and postnatal vitamins, according to the company, and also include Formical (calcium formate), a patented form of calcium that is better absorbed than calcium citrate and calcium carbonate. And both products provide proprietary Quatrefolic, a source of folate that is approximately seven times more bioavailable than folic acid.
HealthSpot, MedAvail Technologies team up to enhance telehealth
DUBLIN, Ohio — HealthSpot has formed a strategic partnership with MedAvail Technologies, which created the MedAvail MedCenter telepharmacy kiosk, to enable HealthSpot station locations to provide pharmacy services in addition to acute care telehealth services in locations where there is no retail pharmacy, such as employer sites and community locations.
The HealthSpot station — a private, walk-in kiosk that enables patients’ immediate access to medical diagnostics from doctors via high-definition videoconferencing and interactive, digital telehealth tools — could now be co-located with a MedAvail MedCenter telepharmacy kiosk, which is currently in pilot phase at locations in Illinois.
The MedCenter could support the dispensing of prescription drugs and OTC medications through live, two-way conferencing with a pharmacist after a visit with a provider inside the HealthSpot station. At the completion of the Healthspot visit, the provider has the ability to send an e-prescription to the MedAvail MedCenter for fulfillment.
"HealthSpot is dedicated to increasing accessibility while creating a truly integrated healthcare experience for the consumer. This experience means being able to receive care from a provider and then easily be able to fill the prescribed meds after the visit and consult with a pharmacist if needed. MedAvail allows consumers to get pharmacy services in non-pharmacy locations and is the perfect addition to HealthSpot’s platform for extended reach of convenient, affordable health care across the country," stated Steve Cashman, founder and CEO of HealthSpot.
"The cooperation we have with HealthSpot will have a significant positive impact on accessibility and health outcomes for consumers," added Ed Kilroy, CEO of MedAvail Technologies. "We believe innovative telehealth solutions like HealthSpot have a consumer-centric edge that pairs well with our vision to bridge the gap for consumers needing pharmacy services."